It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply

Science & Health Apr 14, 2020

Coronavirus drug hopefuls are cheap to make but may quickly be in short supply

by John Miller

Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said. "Any pharmaceutical company manufacturing any treatment currently in clinical trials against coronavirus ...

After Trump threat, India lifts export ban on COVID-19 treatment drug

Asia Pacific / Science & Health Apr 7, 2020

After Trump threat, India lifts export ban on COVID-19 treatment drug

India has partially lifted a ban on the exports of a malaria drug after U.S. President Donald Trump sought supplies for the United States, according to government officials with knowledge of the matter. Exports of hydroxychloroquine and paracetamol will be allowed depending on availability of ...

Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free

National / Science & Health Apr 7, 2020

Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free

Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday. The 20 countries receiving the drug, which is currently undergoing clinical tests, include Bulgaria, the Czech Republic, Indonesia, ...

Fast-moving virus pits treating patients against finding a cure

World / Science & Health | FOCUS Apr 6, 2020

Fast-moving virus pits treating patients against finding a cure

Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't. More than 100 off-the-shelf and experimental therapies are being tested either formally or informally for ...

Japan to boost Avigan drug stockpile as part of coronavirus stimulus

National / Science & Health Apr 5, 2020

Japan to boost Avigan drug stockpile as part of coronavirus stimulus

Japan is considering increasing the stockpile of Fujifilm Holding Corp.'s Avigan anti-flu drug during this fiscal year so it can be used to treat 2 million people.

Firms sign deals with U.S. to prep for mass-producing virus vaccines

Business / Corporate Mar 31, 2020

Firms sign deals with U.S. to prep for mass-producing virus vaccines

The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available. There are ...

National / Science & Health Mar 24, 2020

Japan to join trial to test Ebola drug on COVID-19 patients

The National Center for Global Health and Medicine (NCGM) said Monday that it will join an international clinical trial on the use of remdesivir, which is being developed as a remedy for Ebola, to treat people infected with the new coronavirus. Under the investigator-initiated study, ...

Japanese researchers to test blood thinner for coronavirus treatment

National / Science & Health Mar 19, 2020

Japanese researchers to test blood thinner for coronavirus treatment

A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday. The drug, known by the ...

HIV drug combo fails as treatment for severe COVID-19 in China study

World / Science & Health Mar 19, 2020

HIV drug combo fails as treatment for severe COVID-19 in China study

A pill containing two HIV drugs that was touted as a potential treatment for the novel coronavirus was not effective, according to a study released late on Wednesday in the New England Journal of Medicine. A test in Chinese patients with severe COVID-19 disease found ...

Japan's largest drugmaker working to develop virus treatment, Dow Jones reports

Business Mar 4, 2020

Japan's largest drugmaker working to develop virus treatment, Dow Jones reports

Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said. "We will do all that we can to address the novel coronavirus threat," Dr. Rajeev Venkayya, ...

Japanese government panel OKs expensive gene therapy for rare disease

National / Science & Health Feb 26, 2020

Japanese government panel OKs expensive gene therapy for rare disease

A health ministry panel approved the production and sales of a gene therapy for treating spinal muscular atrophy, a rare incurable disease that destroys muscle function.

Business Feb 26, 2020

U.S. begins first coronavirus clinical trial testing Gilead's experimental drug

U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started. The first trial participant is an American who was repatriated after being quarantined on the Diamond Princess cruise ship ...

« 1 … 35 36 37 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times